Previews

1.C/EBPα in Leukemogenesis: A Matter of Being in the Right Place with the Right Signals

2.A Molecular View of Anti-ErbB Monoclonal Antibody Therapy

3.RanBP2: A Tumor Suppressor with a New Twist on TopoII, SUMO, and Centromeres

4.VHL Inactivation: A New Road to Senescence



Articles

1.Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells

2.Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera

3.Selective Inhibition of JAK2-Driven Erythroid Differentiation of Polycythemia Vera Progenitors

4.Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis

5.The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis

6.Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development

7.Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization